ALS (FRA:CP4) Total Receivables: €379 Mil (As of Mar. 2026)


FRA:CP4 ALS Ltd FRA:CP4
88 GF Score
Price €13.50
GF Value €11.27
Valuation Modestly Overvalued
View Full Analysis

What is ALS Total Receivables?

ALS FRA:CP4 88 Total Receivables is €379 Mil as of Mar. 2026. GuruFocus rates FRA:CP4 with a GF Score™ of 88/100 and a GF Value™ of €11.27 (Modestly Overvalued).

ALS's Total Receivables for the quarter that ended in Mar. 2026 was €379 Mil.

ALS Total Receivables Historical Data

* Premium members only.

The historical data trend for ALS's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ALS Total Receivables Chart

ALS Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 258.87 259.75 327.52 347.44 378.60

ALS Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 327.52 357.11 347.44 360.02 378.60
FRA:CP4
88GF Score
ALS Ltd FRA:CP4
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ALS Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €379 Mil mean?
ALS (FRA:CP4) has a Total Receivables of €379 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on ALS and its competitors.
Is ALS's Total Receivables too high?
ALS's current Total Receivables is €379 Mil. Overall, ALS has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ALS's Total Receivables compare to VRSK and EFX?
ALS's Total Receivables of €379 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Business Services company?
A good Total Receivables depends on the Business Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on ALS and its competitors. ALS's current Total Receivables is €379 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALS stock overvalued right now?
Based on GuruFocus' analysis, ALS (FRA:CP4) is currently considered Modestly Overvalued. The stock's GF Value™ is €11.27, compared to a current price of €13.50 — trading 19.8% above its estimated fair value. The current Total Receivables is €379 Mil. ALS's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For ALS (FRA:CP4), the current Total Receivables is €379 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ALS (FRA:CP4) Overvalued in 2026?

Based on GuruFocus' analysis, ALS stock appears to be overvalued. The current stock price of €13.50 is trading 19.8% above its estimated GF Value™ of €11.27. GuruFocus considers ALS to be Modestly Overvalued.

Key valuation signals for FRA:CP4:

  • Total Receivables: €379 Mil
  • GF Value™: €11.27 vs. price of €13.50 (19.8% above fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the FRA:CP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ALS Business Description

Other Exchanges CPBLF:USAALQ:Australia
Address 25 King Street, Level 9B, Bowen Hills, Brisbane, QLD, AUS, 4006
Founded in the 1880s and listed on the ASX in 1952, ALS operates two divisions: commodities and life sciences. ALS commodities traditionally generated the majority of underlying earnings, providing geochemistry, metallurgy, inspection, and mine site services for the global mining industry. Expansion into environmental, pharmaceutical, and food testing areas has lessened earnings exposure to commodities.
88GF Score

Get the complete analysis for FRA:CP4

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.50
Price
€11.27
GF Value